Amrize AG (AMRZ) slips as earnings depth disappoints
Amrize AG (AMRZ) slips after a modest earnings miss, but the deeper story is softer volume, thinner margins, and weakening cash conversion. Pricing helped offset some pressure, yet adjusted EBITDA barely grew and free cash flow remained negative, tempering the case for a quick rebound.
Amrize AG (AMRZ) reported a modest third-quarter earnings miss, with EPS of $1.02 versus $1.03 expected and revenue of $3.77 billion versus $3.83 billion. The stock slipped as investors focused on weaker cement and aggregates volumes, a 28.5% adjusted EBITDA margin, and negative free cash flow through the first nine months. Pricing gains and cost savings are helping, but the report suggests the recovery is still uneven and cash generation remains the key risk.
Amrize AG (AMRZ) slips after an earnings miss, with third-quarter EPS of $1.02 versus a $1.03 estimate and revenue of $3.77B versus $3.83B. The latest regular-session close was $40.03, down 0.50%, while trading volume reached 7.31 million shares against a 3.95 million average.
The AMRZ earnings print delivered modest growth but little room for celebration. Revenue rose 2.2% year over year, net income increased 3.3% to $558 million, and adjusted EBITDA reached $1.076B, up just 0.2%.
Key Takeaways
Amrize missed both major consensus measures. EPS came in at $1.02 versus $1.03, while revenue reached $3.77B versus $3.83B.
Pricing remained the main support. Cement pricing increased 1.8%, aggregates pricing grew 6.9%, and energy, fuel, and freight surcharges added $23 million.
Building Materials margin expanded by 30 basis points. However, cement volumes fell 4.2% and aggregates volumes declined 0.2%.
Cash conversion weakened. Free cash flow was a use of $551 million during the first nine months, compared with a $186 million use a year earlier.
Management's prior guidance called for the price-over-cost gap to turn positive in the fourth quarter. The ASPIRE program also remains on track for $80 million of savings this year and $250 million through 2028.
The analyst consensus remains Hold, with four Buy ratings, five Holds, and two Sells. Before the report, Wells Fargo downgraded AMRZ and Barclays cut its target.
Financial Performance: AMRZ Earnings Miss on EPS and Revenue
Amrize generated $3.771B of third-quarter revenue, a 2.2% increase from the prior year. That growth fell short of the $3.83B consensus estimate. The gap was modest in absolute terms, but it matters because adjusted EBITDA growth nearly stalled at 0.2%.
Net income rose 3.3% to $558 million. Reported EPS was $1.02, compared with $0.87 in the second quarter and $0.98 in the October 2025 earnings history. The recent pattern remains uneven. EPS was $0.88 in August 2026, negative $0.16 in April, and $0.62 in February.
The quality of growth deserves more attention than the headline revenue increase. Adjusted diluted EPS was $1.05, unchanged from the prior-year quarter. Adjusted EBITDA margin slipped to 28.5% from 29.1%, even as Building Materials margin expanded by 30 basis points.
Pricing helped offset weaker physical volumes. Cement volumes fell 4.2% year over year, while aggregates volumes declined 0.2%. Cement pricing rose 1.8%, and aggregates pricing grew 6.9%. The result is a familiar construction-materials tradeoff: stronger price realization is protecting revenue, but volume has not followed.
Building Materials remains the clearest segment read-through. In the second quarter, the segment generated $2.4B of revenue, up 8.2%, with organic growth of 5.6%. Cement volumes increased 5% then, while supplementary cementitious materials posted double-digit volume growth. The third-quarter volume figures show that momentum became less consistent.
Cost inflation also restrained operating leverage. Amrize cited energy, fuel, and freight pressure, with surcharges contributing $23 million. The company invested heavily as well. First-nine-month free cash flow was a $551 million use, versus a $186 million use in the prior-year period, driven by lower operating cash flow and higher capital spending.
Capital returns provide a counterweight. Amrize returned $1.1B to shareholders during the first nine months and completed its $1B share repurchase program on October 28. The board also declared a $0.11 quarterly dividend payable on November 18.
Market Reaction and Analyst Response
AMRZ closed at $40.03 in the latest regular session, down 0.50%. Volume reached 7,310,608 shares, compared with an average of 3,948,492. That activity gives the price move more weight than a quiet decline, although the quoted session closed before the October 28 earnings report.
The broader analyst stance is cautious. The consensus rating is Hold, based on four Buys, five Holds, and two Sells. That balance reflects a company with strong exposure to data centers, infrastructure, and domestic manufacturing, but with weaker volume and cash-flow figures.
The clearest target resets came before the earnings report. Wells Fargo analyst Timna Tanners downgraded Amrize from Overweight to Equal-Weight on September 9 and cut the price target from $55 to $44. Barclays analyst Adam Seiden maintained Equal-Weight on October 19 while reducing the target from $55 to $40.
Those target cuts frame the AMRZ earnings miss in practical terms. At $40.03, the stock sits near Barclays' revised target and below Wells Fargo's $44 target. The market therefore has less tolerance for another quarter of weak volume or cash usage.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
CEO Jan Jenisch has built the Amrize narrative around long-cycle demand. His comments link the business to data centers, energy projects, infrastructure modernization, and advanced manufacturing. That theme remains important because those projects carry larger material requirements than ordinary residential construction.
“Growth trends from infrastructure modernization and onshoring of manufacturing to data center expansion and the digital economy are taking shape on the ground.” - Jan Jenisch, Chairman and CEO, Second-Quarter 2026 Earnings Call
Jenisch also described the latest quarter as producing “resilient results,” supported by pricing, acquisitions, and the ASPIRE program. The strategy is clear: invest in local production, connect cement and aggregates networks, and capture demand from large regional projects.
“Overall, we expect the price over cost gap to improve in the second half and turn positive in Q4 with improving trends as we enter 2027.” - Baris Oran, CFO, Second-Quarter 2026 Earnings Call
CFO Baris Oran's guidance provides the financial test for that strategy. Amrize needs pricing and surcharges to outrun freight, diesel, and raw-material inflation. Third-quarter pricing data show progress, but the 28.5% adjusted EBITDA margin and flat adjusted EPS show that cost pressure still absorbs much of the benefit.
ASPIRE offers another earnings lever. The program delivered $29 million of savings in the second quarter, with a target of $80 million for 2026. Those savings matter more when volume growth slows because procurement and logistics gains can support profit without relying entirely on higher prices.
The investment plan also remains aggressive. Amrize completed a 660,000-ton cement expansion in Missouri, is adding 100,000 tons in Texas, and is expanding capacity in Quebec and Alberta. The company also acquired Rapid Redi-Mix in Texas and said the deal is expected to add EPS value this year.
Bottom Line
Amrize AG earnings show a business with real exposure to attractive infrastructure and data-center projects, but the latest numbers expose weaker volumes, softer cash conversion, and limited margin expansion. The investment case improves if pricing, ASPIRE savings, and acquisitions turn into stronger EBITDA growth in the fourth quarter and into 2027.
+Did Amrize AG (AMRZ) beat earnings expectations in the third quarter?
No. Amrize AG (AMRZ) reported third-quarter EPS of $1.02 versus the $1.03 consensus estimate, and revenue of $3.77 billion versus the $3.83 billion estimate. The miss was small, but it came alongside nearly flat adjusted EBITDA growth.
+Why did Amrize stock fall after the earnings report?
The stock fell because investors focused on the earnings miss, weaker volumes, and soft cash generation. Cement volumes declined 4.2% year over year, aggregates volumes slipped 0.2%, and free cash flow was a $551 million use in the first nine months.
+What were the main positives in Amrize's Q3 earnings?
Pricing remained the main support, with cement pricing up 1.8% and aggregates pricing up 6.9%. Amrize also expanded Building Materials margin by 30 basis points and reported net income of $558 million, up 3.3% from a year earlier.
+What is the analyst view on Amrize AG (AMRZ) after the report?
The analyst consensus remains Hold, with four Buy ratings, five Holds, and two Sells. Wells Fargo downgraded the stock and Barclays cut its target, leaving the shares near the revised valuation range after the report.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on AMRZ?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
